Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 451641 - 451660 out of 485545 entries
Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
---|---|---|---|---|---|---|---|---|
Switzerland | (L04AF01) tofacitinib (adm: O) | Xeljanz, Filmtabl 10 mg, 56 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | PfizerAG |
Switzerland | (L04AF01) tofacitinib (adm: O) | Xeljanz, Filmtabl 5 mg, 56 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | PfizerAG |
Switzerland | (L04AF02) baricitinib (adm: O) | Olumiant, Filmtabl 2 mg, 28 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | EliLilly(Suisse)SA |
Switzerland | (L04AF02) baricitinib (adm: O) | Olumiant, Filmtabl 4 mg, 28 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | EliLilly(Suisse)SA |
Switzerland | (L04AG03) natalizumab (adm: P) | Tysabri, Inf Konz 300 mg/15ml, Fl 15 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Sclerosis | BiogenSwitzerlandAG |
Switzerland | (L04AG03) natalizumab (adm: P) | Tysabri, Inj Lös 150 mg/ml, 2 Fertspr 1 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Sclerosis | BiogenSwitzerlandAG |
Switzerland | (L04AG04) belimumab (adm: P) | Benlysta, Inj Lös 200 mg/ml Autoinjektor, 4 Injektor 1 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | GlaxoSmithKlineAG |
Switzerland | (L04AG04) belimumab (adm: P) | Benlysta, Inj Lös 200 mg/ml Autoinjektor, Injektor 1 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | GlaxoSmithKlineAG |
Switzerland | (L04AG04) belimumab (adm: P) | Benlysta, Trockensub 120 mg, 1 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | GlaxoSmithKlineAG |
Switzerland | (L04AG04) belimumab (adm: P) | Benlysta, Trockensub 400 mg, 1 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | GlaxoSmithKlineAG |
Switzerland | (L04AG05) vedolizumab (adm: P) | Entyvio subkutan, Inj Lös 108 mg/0.68ml Fertigpen, Fertpen 1 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
Colitis, Ulcerative; Crohn Disease | TakedaPharmaAG |
Switzerland | (L04AG05) vedolizumab (adm: P) | Entyvio subkutan, Inj Lös 108 mg/0.68ml Fertigspritze, Fertspr 1 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
Colitis, Ulcerative; Crohn Disease | TakedaPharmaAG |
Switzerland | (L04AG05) vedolizumab (adm: P) | Entyvio, Trockensub 300 mg, Durchstf 1 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
Colitis, Ulcerative; Crohn Disease | TakedaPharmaAG |
Switzerland | (L04AG08) ocrelizumab (adm: P) | Ocrevus, Inf Konz 300 mg/10 ml, Durchstf 1 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Sclerosis | RochePharma(Schweiz)AG |
Switzerland | (L04AG11) anifrolumab (adm: P, previous atc code l04aa51. new atc 4th level l04ag valid from january 2024.) | Saphnelo, Inf Konz 300 mg/2ml, Durchstf 1 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | AstraZenecaAG |
Switzerland | (L04AH01) sirolimus (adm: O) | Rapamune, Lös 1 mg/ml, Fl 60 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Graft Rejection; Kidney Transplantation | PfizerAG |
Switzerland | (L04AH01) sirolimus (adm: O) | Rapamune, Tabl 0.5 mg, 30 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
Graft Rejection; Kidney Transplantation | PfizerAG |
Switzerland | (L04AH01) sirolimus (adm: O) | Rapamune, Tabl 1 mg, 100 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
Graft Rejection; Kidney Transplantation | PfizerAG |
Switzerland | (L04AH01) sirolimus (adm: O) | Rapamune, Tabl 1 mg, 30 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
Graft Rejection; Kidney Transplantation | PfizerAG |
Switzerland | (L04AH01) sirolimus (adm: O) | Rapamune, Tabl 2 mg, 100 Stk | n/a | Retail price with vat |
$0-0 |
$0-0 |
Graft Rejection; Kidney Transplantation | PfizerAG |